{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:16:57Z","timestamp":1788499017051,"version":"build-2803163510"},"reference-count":30,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009088","name":"University of Veterinary Medicine Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009088","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/01w6qp003","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>Background: Non-associative immune-mediated hemolytic anemia (IMHA) is uncommon in cats and carries substantial mortality. Glucocorticoids are first-line treatment, and cyclosporin A (CsA) is frequently added, but data on the clinical course and long-term outcome are limited. We describe clinical findings, treatment, adverse events and outcome in cats with non-associative IMHA. Methods: In this retrospective observational single-center study (October 2014\u2013October 2024), 37 cats diagnosed by the 2019 ACVIM consensus criteria were included; 15 received prednisolone alone (PG) and 22 prednisolone combined with CsA (CPG), allocated at the clinician\u2019s discretion. Between-cohort comparisons are exploratory. Results: Cats in the CPG cohort presented with more severe anemia. Overall mortality was 24.3%, with all deaths within four weeks; survival to discharge was 13\/15 (PG) and 19\/22 (CPG). Median follow-up was 50 [8\u2013430] and 70 days [12\u2013330]. Two cats achieved sustained treatment-free remission of 4.2 and 1.9 years. Five cats relapsed, four while receiving ongoing immunosuppression. Conclusions: Most cats survived the acute phase but required prolonged immunosuppression, and sustained treatment-free remission was uncommon. Relapses occurred predominantly during ongoing therapy rather than after discontinuation. Because CsA was used preferentially in more severely affected cats, comparative efficacy cannot be assessed and remains to be addressed prospectively.<\/jats:p>","DOI":"10.3390\/ani16172727","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:53:11Z","timestamp":1788335591000},"page":"2727","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Findings, Treatment and Long-Term Outcome in 37 Cats with Non-Associative Immune-Mediated Hemolytic Anemia: A Retrospective Observational Study of Two Treatment Cohorts"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2568-9249","authenticated-orcid":false,"given":"Lisa-Maria","family":"Kulmer","sequence":"first","affiliation":[{"name":"Clinical Unit of Small Animals Internal Medicine, Department for Companion Animals and Horses, University of Veterinary Medicine Vienna, 1210 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8731-2936","authenticated-orcid":false,"given":"Pavlos G.","family":"Doulidis","sequence":"additional","affiliation":[{"name":"Clinical Unit of Small Animals Internal Medicine, Department for Companion Animals and Horses, University of Veterinary Medicine Vienna, 1210 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8516-0040","authenticated-orcid":false,"given":"Iwan A.","family":"Burgener","sequence":"additional","affiliation":[{"name":"Clinical Unit of Small Animals Internal Medicine, Department for Companion Animals and Horses, University of Veterinary Medicine Vienna, 1210 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-3075","authenticated-orcid":false,"given":"Nicole","family":"Luckschander-Zeller","sequence":"additional","affiliation":[{"name":"Clinical Unit of Small Animals Internal Medicine, Department for Companion Animals and Horses, University of Veterinary Medicine Vienna, 1210 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jvim.15441","article-title":"ACVIM Consensus Statement on the Diagnosis of Immune-Mediated Hemolytic Anemia in Dogs and Cats","volume":"33","author":"Garden","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1939-1676.2006.tb02836.x","article-title":"Primary Immune-Mediated Hemolytic Anemia in 19 Cats: Diagnosis, Therapy, and Outcome (1998\u20132004)","volume":"20","author":"Kohn","year":"2006","journal-title":"J. Vet. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jvim.13658","article-title":"Demographic Characteristics, Survival and Prognostic Factors for Mortality in Cats with Primary Immune-Mediated Hemolytic Anemia","volume":"30","author":"Swann","year":"2016","journal-title":"J. Vet. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/1098612X15588800","article-title":"Feline Non-Regenerative Immune-Mediated Anaemia: Features and Outcome in 15 Cases","volume":"18","author":"Black","year":"2016","journal-title":"J. Feline Med. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-3164.2008.00717.x","article-title":"Glucocorticoids in the Cat","volume":"19","author":"Lowe","year":"2008","journal-title":"Vet. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cvsm.2022.01.009","article-title":"Glucocorticoids, Cyclosporine, Azathioprine, Chlorambucil, and Mycophenolate in Dogs and Cats: Clinical Uses, Pharmacology, and Side Effects","volume":"52","author":"Viviano","year":"2022","journal-title":"Vet. Clin. N. Am.-Small Anim. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jfms.2007.02.001","article-title":"Feline Diabetes Mellitus in the UK: The Prevalence within an Insured Cat Population and a Questionnaire-Based Putative Risk Factor Analysis","volume":"9","author":"McCann","year":"2007","journal-title":"J. Feline Med. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/1098612X17748718","article-title":"Ciclosporin and the Cat: Current Understanding and Review of Clinical Use","volume":"20","author":"Colombo","year":"2018","journal-title":"J. Feline Med. Surg."},{"key":"ref_9","unstructured":"Husbands, B.D., Smith, S.A., and Weiss, D.J. (2002). Idiopathic Immune-Mediated Hemolytic Anemia (IMHA) in 25 Cats, American College of Veterinary Internal Medicine."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/avj.12875","article-title":"Primary Immune-Mediated Haemolytic Anaemia: A Retrospective Long-Term Study in 61 Dogs","volume":"97","author":"Weingart","year":"2019","journal-title":"Aust. Vet. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e70101","DOI":"10.1111\/jvim.70101","article-title":"Retrospective Evaluation of Hematological Ratios in Dogs With Nonassociative Immune-Mediated Hemolytic Anemia: 206 Cases","volume":"39","author":"Duclos","year":"2025","journal-title":"J. Vet. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jvim.13642","article-title":"Predicting Outcome in Dogs with Primary Immune-Mediated Hemolytic Anemia: Results of a Multicenter Case Registry","volume":"29","author":"Goggs","year":"2015","journal-title":"J. Vet. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/vec.13204","article-title":"2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1\u2014Defining Populations at Risk","volume":"32","author":"deLaforcade","year":"2022","journal-title":"J. Vet. Emerg. Crit. Care"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Yoshida, T., Mandour, A.S., Sato, M., Hirose, M., Kikuchi, R., Komiyama, N., Hendawy, H.A., Hamabe, L., Tanaka, R., and Matsuura, K. (2022). Pulmonary Thromboembolism Due to Immune-Mediated Hemolytic Anemia in a Cat: A Serial Study of Hematology and Echocardiographic Findings. Front. Vet. Sci., 9.","DOI":"10.3389\/fvets.2022.930210"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1748-5827.2007.00325.x","article-title":"Frequencies of Feline Blood Types at a Referral Hospital in the South East of England","volume":"48","author":"Forcada","year":"2007","journal-title":"J. Small Anim. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gavazza, A., Rossi, G., Antognoni, M.T., Cerquetella, M., Miglio, A., and Mangiaterra, S. (2021). Feline Blood Groups: A Systematic Review of Phylogenetic and Geographical Origin. Animals, 11.","DOI":"10.3390\/ani11123339"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2460\/javma.22.03.0109","article-title":"Canine and Feline Core Vaccinations: US Veterinarians\u2019 Concerns and Perceived Impact of COVID-19 Antivaccination Views on Veterinary Medicine","volume":"260","author":"Kogan","year":"2022","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1939-1676.1996.tb02064.x","article-title":"Vaccine-Associated Immune-Mediated Hemolytic Anemia in the Dog","volume":"10","author":"Duval","year":"1996","journal-title":"J. Vet. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1292\/jvms.09-0283","article-title":"Evaluation of Prognostic Factors and Establishment of a Prognostic Scoring System for Canine Primary Immune-Mediated Hemolytic Anemia","volume":"72","author":"Ishihara","year":"2010","journal-title":"J. Vet. Med. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Barcellini, W., Zaninoni, A., Giannotta, J.A., and Fattizzo, B. (2020). New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy Stage 1. J. Clin. Med., 9.","DOI":"10.3390\/jcm9123859"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1939-1676.2009.0282.x","article-title":"Serum Acute Phase Protein Concentrations in Dogs with Autoimmune Hemolytic Anemia","volume":"23","author":"Mitchell","year":"2009","journal-title":"J. Vet. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/jvim.15463","article-title":"ACVIM Consensus Statement on the Treatment of Immune-Mediated Hemolytic Anemia in Dogs","volume":"33","author":"Swann","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Elkholly, D.A., Brodbelt, D.C., Church, D.B., Pelligand, L., Mwacalimba, K., Wright, A.K., and O\u2019Neill, D.G. (2020). Side Effects to Systemic Glucocorticoid Therapy in Dogs Under Primary Veterinary Care in the UK. Front. Vet. Sci., 7.","DOI":"10.3389\/fvets.2020.00515"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13620-024-00277-w","article-title":"Clinical Presentation, Outcome and Prognostic Factors in Dogs with Immune-Mediated Haemolytic Anaemia: A Retrospective Single-Centre Study of 104 Cases in Ireland (2002\u20132020)","volume":"77","author":"Duclos","year":"2024","journal-title":"Ir. Vet. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2885.2003.00496.x","article-title":"Disposition of Cyclosporine after Intravenous and Multi-Dose Oral Administration in Cats","volume":"26","author":"Mehl","year":"2003","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kong, J., Yang, Y., Liu, Y., Cao, Y., Qiu, J., Sun, P., and Cao, X. (2023). The Pharmacokinetic and Absolute Bioavailability of Cyclosporine (Atopica for Cats) in Cats. Vet. Sci., 10.","DOI":"10.3390\/vetsci10060399"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"R\u00f6sch, S., Frommeyer, A., Schulte Bocholt, J., Grote-Koska, D., Brand, K., and Mischke, R. (2024). Progression of Cyclosporine A-Blood Levels in Experimental Cats Receiving a High-Dose Treatment Protocol. Front. Vet. Sci., 11.","DOI":"10.3389\/fvets.2024.1444586"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/1098612X20941785","article-title":"Feline Leukaemia Virus Infection: A Practical Approach to Diagnosis","volume":"22","author":"Hartmann","year":"2020","journal-title":"J. Feline Med. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1098612X19895940","article-title":"2020 AAFP Feline Retrovirus Testing and Management Guidelines","volume":"22","author":"Little","year":"2020","journal-title":"J. Feline Med. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Perez-Ecija, A., Martinez, C., Fernandez-Casta\u00f1er, J., and Mendoza, F.J. (2024). The Immature Reticulocyte Fraction (IRF) in the Sysmex XN-1000V Analyzer Can Differentiate between Causes of Regenerative and Non-Regenerative Anemia in Dogs and Cats. Animals, 14.","DOI":"10.3390\/ani14020349"}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/16\/17\/2727\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:28:32Z","timestamp":1788496112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/16\/17\/2727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":30,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ani16172727"],"URL":"https:\/\/doi.org\/10.3390\/ani16172727","relation":{},"ISSN":["2076-2615"],"issn-type":[{"value":"2076-2615","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]}}}